Chemical Class
Phenethylamine
Psychoactive Class
Depressant
Pharmacology
DrugBank
State Solid
Metabolism Hepatic.
Description
The Food and Drug Administration suspended the marketing authorisation for Survector in 1999 and France withdrew it from the market, however several developing countries continued to produce it up until 2005.
Mechanism of Action
Amineptine selectively inhibits the reuptake of dopamine and to a lesser extent norepinephrine, thus exerting a powerful and fast-acting antidepressant effect.
Pharmacodynamics
Amineptine is an atypical tricyclic antidepressant.
Indication
For the treatment of depression.
Half-life
48 minutes for the parent drug and 2.5 hours for the metabolites.
Tolerance & Pharmacokinetics
drugs.wikiTolerance Decay
Full tolerance
1h
Half tolerance
10d
Baseline
~14d
Experience Report Analysis
Erowid
1
Reports
2004–2004
Date Range
Demographics
Gender Distribution
Reports Over Time
Real-World Dose Distribution
62K DosesFrom 5 individual dose entries
Oral (n=5)
Median: 100.0mg
25th: 25.0mg
75th: 200.0mg
90th: 200.0mg
mg/kg median: 1.422
mg/kg 75th: 2.845